The field of urologic oncology is experiencing rapid developments in recent years, fueled by breakthroughs in diagnosis, treatment, and patient care. Novel therapeutic approaches such as targeted therapy and immunotherapy are altering the landscape of urologic cancer management. Additionally, advancements in imaging techniques enable earlier and mo